Therapeutic Targets Database
BIDD Pharmainformatics Databases


Target Validation Information
Target NameOxysterols receptor LXR-alpha    
Type of TargetResearch target    
Drug Potency against TargetGW-3965IC50 = 100 nM[1]
WAY-254011IC50 = 10000 nM[2]
2-(2-hexylphenyl)isoindoline-1,3-dioneIC50 = 13000 nM[3]
WAY-252623IC50 = 179 nM[1]
GSK-9772IC50 = 180 nM[4]
WAY-214950IC50 = 248 nM[1]
2-Benzyl-3-phenyl-7-(trifluoromethyl)-2H-indazoleIC50 = 279 nM[1]
4,17-dehydroxyriccardin CIC50 = 3200 nM[3]
Guttiferone IIC50 = 3400 nM[5]
12-dehydroxyriccardin CIC50 = 4400 nM[3]
riccardin CIC50 = 4900 nM[3]
12,17-dehydroxyriccardin CIC50 = 5700 nM[3]
17-dehydroxyriccardin CIC50 = 6600 nM[3]
4,12,17-dehydroxyriccardin CIC50 = 7100 nM[3]
4-dehydroxyriccardin CIC50 = 8400 nM[3]
WAY-254011IC50 = 9.5 nM[6]
2-(2-phenethylphenyl)isoindoline-1,3-dioneIC50 = 9800 nM[7]
Ref 1J Med Chem. 2008 Nov 27;51(22):7161-8.Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis. To Reference
Ref 2Bioorg Med Chem. 2009 May 15;17(10):3519-27. Epub 2009 Apr 12.Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta. To Reference
Ref 3Bioorg Med Chem. 2008 Apr 15;16(8):4272-85. Epub 2008 Feb 29.Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development. To Reference
Ref 4J Med Chem. 2008 Sep 25;51(18):5758-65.Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity. To Reference
Ref 5J Nat Prod. 2005 Apr;68(4):617-9.Guttiferone I, a new prenylated benzophenone from Garcinia humilis as a liver X receptor ligand. To Reference
Ref 6Bioorg Med Chem. 2009 Dec 1;17(23):8086-92. Epub 2009 Oct 4.4-(3-aryloxyaryl)quinoline alcohols are liver X receptor agonists. To Reference
Ref 7Bioorg Med Chem. 2009 Jul 15;17(14):5001-14. Epub 2009 Jun 2.Separation of alpha-glucosidase-inhibitory and liver X receptor-antagonistic activities of phenethylphenyl phthalimide analogs and generation of LXRalpha-selective antagonists. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543